Heineken will take over the majority ownership of the Long Chuan Zuan Co brewery in Taiwan from the Sanyo Whisbih Groupo.
The agreement's financial details have not been disclosed.
The Investment Commission of Taiwan's Ministry of Economic Affairs has approved the transaction, which is still subject to closing requirements.
With investment in Taiwan's domestic manufacturing, Heineken will be the first foreign brewer to have a brewery in the nation.
Long Chuan is a product of the Taiwan Tsing Beer Corporation, which is a subsidiary of the Sanyo Whisbih Group. It is anticipated that Heineken will become the brand's sole owner, making it an even more formidable rival to the state-owned Taiwan Beer.
Before opening an office there in 2002, the company originally brought Heineken beer to Taiwan in 1987. The brewer operates six locations around the nation, where it registers about $201.9 million in revenue annually.


TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
What’s the difference between baking powder and baking soda? It’s subtle, but significant
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Can your cat recognise you by scent? New study shows it’s likely
The pandemic is still disrupting young people’s careers
South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Thailand Inflation Remains Negative for 10th Straight Month in January
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Trump Endorses Japan’s Sanae Takaichi Ahead of Crucial Election Amid Market and China Tensions
Washington Post Publisher Will Lewis Steps Down After Layoffs
AI is driving down the price of knowledge – universities have to rethink what they offer
U.S. Stock Futures Slide as Tech Rout Deepens on Amazon Capex Shock
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 



